Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Chan

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Path integration selectively predicts midlife risk of Alzheimer's diseaseCoco Newton, Marianna Pope, Catarina Rua, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 29, 2024
Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's diseaseCoco Newton, Marianna Pope, Catarina Rua, et al.
Brain, Behavior, and Immunity|May 12, 2024
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant)Paul Foret-Bruno, Roz Shafran, Terence Stephenson, et al.
JAMA Network Open|July 1, 2026
Cognitive Rehabilitation and Functional Outcomes in Long COVID-Related Cognitive Impairment: A Randomized Clinical TrialMartina Vanova, Aysha Mohamed Rafik Patel, Iona Scott, et al.
Trials|October 21, 2024
Telehealth-delivered cognitive rehabilitation for people with cognitive impairment as part of the post-COVID syndrome: protocol for a randomised controlled trial as part of the CICERO (Cognitive Impairment in Long COVID: Phenotyping and Rehabilitation) studyMartina Vanova, Aysha Mohamed Rafik Patel, Iona Scott, et al.
BMJ Open|March 25, 2019
Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's diseaseIvan Koychev, Jennifer Lawson, Tharani Chessell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersDavid Berron, Stefano F Cappa, John Clarkson, et al.
Brain Communications|November 9, 2022
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerabilityBryan Ng, Helen A Rowland, Tina Wei, et al.
Stem Cells (Dayton, Ohio)|December 20, 2024
Changes in iPSC-astrocyte morphology reflect Alzheimer's disease patient clinical markersHelen A Rowland, Georgina Miller, Qiang Liu, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Path integration selectively predicts midlife risk of Alzheimer's diseaseCoco Newton, Marianna Pope, Catarina Rua, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 29, 2024
Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's diseaseCoco Newton, Marianna Pope, Catarina Rua, et al.
Brain, Behavior, and Immunity|May 12, 2024
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant)Paul Foret-Bruno, Roz Shafran, Terence Stephenson, et al.
JAMA Network Open|July 1, 2026
Cognitive Rehabilitation and Functional Outcomes in Long COVID-Related Cognitive Impairment: A Randomized Clinical TrialMartina Vanova, Aysha Mohamed Rafik Patel, Iona Scott, et al.
Trials|October 21, 2024
Telehealth-delivered cognitive rehabilitation for people with cognitive impairment as part of the post-COVID syndrome: protocol for a randomised controlled trial as part of the CICERO (Cognitive Impairment in Long COVID: Phenotyping and Rehabilitation) studyMartina Vanova, Aysha Mohamed Rafik Patel, Iona Scott, et al.
BMJ Open|March 25, 2019
Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's diseaseIvan Koychev, Jennifer Lawson, Tharani Chessell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersDavid Berron, Stefano F Cappa, John Clarkson, et al.
Brain Communications|November 9, 2022
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerabilityBryan Ng, Helen A Rowland, Tina Wei, et al.
Stem Cells (Dayton, Ohio)|December 20, 2024
Changes in iPSC-astrocyte morphology reflect Alzheimer's disease patient clinical markersHelen A Rowland, Georgina Miller, Qiang Liu, et al.
Pageof 8